Non-Hodgkin lymphoma, all (controls excluding all cancers)

C3_NONHODGKIN_EXALLC

No definition available.

Endpoint definition

FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Cause of death: ICD-10 C82, C83, C84, C85
Cause of death: ICD-9 200
Cancer registry: Topography ICD-O-3 ANY
Cancer registry: Morphology ICD-O-3 967[0-9]|970[0-2]
Cancer registry: Behaviour codes 3

2 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

1072

diagram downward connector
C3_NONHODGKIN_EXALLC

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze DF9

Similar endpoints

List of similar endpoints to Non-Hodgkin lymphoma, all (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 1072 330 742
Unadjusted prevalence (%) 0.26 0.14 0.41
Mean age at first event (years) 69.27 67.27 70.17

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: C3_NONHODGKIN_EXALLC – Non-Hodgkin lymphoma, all (controls excluding all cancers)
GWS hits:

Survival analyses between endpoints

Plot

before Non-Hodgkin lymphoma, all (controls excluding all cancers)
after Non-Hodgkin lymphoma, all (controls excluding all cancers)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Non-Hodgkin lymphoma, all (controls excluding all cancers)

Endpoint not on priority list, no data to show.